沃森生物：水痘减毒活疫苗获《药物临床试验批准通知书》

Group 1 - The core point of the article is that Watson Bio and its subsidiaries have received approval from the National Medical Products Administration for clinical trials of a varicella live attenuated vaccine [1] Group 2 - The clinical trial aims to prevent chickenpox [1] - The companies involved in the development and application for the clinical trial include Yunnan Vaccine Laboratory Co., Ltd., Beijing Watson Innovative Biotechnology Co., Ltd., and Yuxi Watson Biotechnology Co., Ltd. [1]